These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 27334029)

  • 1. Optical Coherence Tomography of De Novo Lesions and In-Stent Restenosis in Coronary Saphenous Vein Grafts (OCTOPUS Study).
    Roleder T; Pociask E; Wańha W; Dobrolińska M; Gąsior P; Smolka G; Walkowicz W; Jadczyk T; Bochenek T; Dudek D; Ochała A; Mizia-Stec K; Gąsior Z; Tendera M; Ali ZA; Wojakowski W
    Circ J; 2016 Jul; 80(8):1804-11. PubMed ID: 27334029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
    Hougaard M; Thayssen P; Kaltoft A; Tilsted HH; Maeng M; Lassen JF; Thuesen L; Okkels Jensen L
    Catheter Cardiovasc Interv; 2014 Jun; 83(7):1035-42. PubMed ID: 24311384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous intervention in saphenous venous grafts: in-stent restenosis lesions are safer than de novo lesions.
    Assali AR; Sdringola S; Moustapha A; Ghani M; Achour H; Hale S; Schroth G; Fujise K; Anderson HV; Smalling RW; Rosales OR
    J Invasive Cardiol; 2001 Jun; 13(6):446-50. PubMed ID: 11385167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of optical coherence tomography of early and very late stent restenosis after drug-eluting stent implantation].
    Liu ZJ; Shi B; Deng CC; Xu GX; Zhao RZ; Shen CY; Wang ZL; Liu HL
    Zhonghua Yi Xue Za Zhi; 2017 Jun; 97(23):1778-1783. PubMed ID: 28647998
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical outcome of percutaneous treatment of in-stent restenosis with drug-eluting stents: results from the first phase of the prospective multicentre German DES.DE registry.
    Abdel-Wahab M; Nienaber CA; Mostafa AE; Sabin G; Tebbe U; Hochadel M; Senges J; Akin I; Kuck KH; Hamm C; Richardt G;
    EuroIntervention; 2011 Jun; 7(2):201-8. PubMed ID: 21646062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular Ultrasound Assessment of In-Stent Restenosis in Saphenous Vein Grafts.
    Wolny R; Mintz GS; Matsumura M; Ishida M; Fan Y; Fall KN; Parikh MA; Rabbani LE; Ali ZA; Karmpaliotis D; Kirtane AJ; Moses JW; Maehara A
    Am J Cardiol; 2019 Apr; 123(7):1052-1059. PubMed ID: 30642605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical coherence tomography analysis of the stenting of saphenous vein graft (SOS) Xience V Study: use of the everolimus-eluting stent in saphenous vein graft lesions.
    Papayannis AC; Michael TT; Yangirova D; Abdel-Karim AR; Kohlhaas J; Mahmood A; Addo T; Haagen D; Makke L; Roesle M; Rangan B; Banerjee S; Brilakis ES
    J Invasive Cardiol; 2012 Aug; 24(8):390-4. PubMed ID: 22865309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.
    Suzuki N; Kozuma K; Kyono H; Nakaya H; Nishide S; Mitsui M; Nara Y; Kawashima H; Nomura T; Yamamoto H; Sasajima Y; Kondo F; Isshiki T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):210-7. PubMed ID: 26608163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: results from the Prairie "Real World" Stent Registry.
    Goswami NJ; Gaffigan M; Berrio G; Plessa AL; Pfeiffer AM; Markwell SJ; Mishkel GJ
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):93-100. PubMed ID: 19787803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
    Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes with drug-eluting versus bare-metal stents in saphenous vein graft intervention results from the STENT (strategic transcatheter evaluation of new therapies) group.
    Brodie BR; Wilson H; Stuckey T; Nussbaum M; Laurent S; Bradshaw B; Humphrey A; Metzger C; Hermiller J; Krainin F; Juk S; Cheek B; Duffy P; Simonton CA;
    JACC Cardiovasc Interv; 2009 Nov; 2(11):1105-12. PubMed ID: 19926052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART program.
    Aggarwal V; Stanislawski MA; Maddox TM; Nallamothu BK; Grunwald G; Adams JC; Ho PM; Rao SV; Casserly IP; Rumsfeld JS; Brilakis ES; Tsai TT
    J Am Coll Cardiol; 2014 Oct; 64(17):1825-36. PubMed ID: 25443706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and clinical effectiveness of drug-eluting stents for saphenous vein graft intervention in older individuals: Results from the medicare-linked National Cardiovascular Data Registry(®) CathPCI Registry(®) (2005-2009).
    Brennan JM; Sketch MH; Dai D; Trilesskaya M; Al-Hejily W; Rao SV; Brilakis E; Messenger JC; Shaw RE; Anstrom KJ; Peterson ED; Douglas PS
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):43-9. PubMed ID: 26153480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical coherence tomography for the assessment of pericardium covered stents for the treatment of degenerated saphenous vein grafts.
    Tyczynski P; Kukreja N; van Geuns RJ; Wykrzykowska JJ; Sheppard MN; Di Mario C
    EuroIntervention; 2010 May; 6(1):78-85. PubMed ID: 20542801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued benefit from paclitaxel-eluting compared with bare-metal stent implantation in saphenous vein graft lesions during long-term follow-up of the SOS (Stenting of Saphenous Vein Grafts) trial.
    Brilakis ES; Lichtenwalter C; Abdel-karim AR; de Lemos JA; Obel O; Addo T; Roesle M; Haagen D; Rangan BV; Saeed B; Bissett JK; Sachdeva R; Voudris VV; Karyofillis P; Kar B; Rossen J; Fasseas P; Berger P; Banerjee S
    JACC Cardiovasc Interv; 2011 Feb; 4(2):176-82. PubMed ID: 21349456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial).
    Xenogiannis I; Rangan BV; Uyeda L; Banerjee S; Edson R; Bhatt DL; Goldman S; Holmes DR; Rao SV; Shunk K; Mavromatis K; Ramanathan K; Bavry AA; McFalls EO; Garcia S; Thai H; Uretsky BF; Latif F; Armstrong E; Ortiz J; Jneid H; Liu J; Aggrawal K; Conner TA; Wagner T; Karacsonyi J; Ventura B; Alsleben A; Lu Y; Shih MC; Brilakis ES
    Am J Cardiol; 2022 Jan; 162():24-30. PubMed ID: 34736721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different Neointimal Pattern in Early vs. Late In-Stent Restenosis and Clinical Outcomes After Drug-Coated Balloon Angioplasty　- An Optical Coherence Tomography Study.
    Lee JH; Jung HW; Kim JS; Hong SJ; Ahn CM; Kim BK; Ko YG; Choi D; Hong MK; Jang Y
    Circ J; 2018 Oct; 82(11):2745-2752. PubMed ID: 30197402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
    Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
    Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.